CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 189 filers reported holding CARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,426,060 | +496.1% | 848,845 | +904.2% | 0.29% | +551.1% |
| Q2 2023 | $239,220 | -42.4% | 84,530 | 0.0% | 0.04% | -43.8% |
| Q1 2023 | $415,042 | -49.4% | 84,530 | +10.8% | 0.08% | -52.4% |
| Q4 2022 | $819,731 | +20.7% | 76,325 | +5.2% | 0.17% | +9.8% |
| Q3 2022 | $679,000 | -44.0% | 72,529 | -45.4% | 0.15% | -36.2% |
| Q2 2022 | $1,213,000 | -21.1% | 132,879 | +5.0% | 0.24% | -4.4% |
| Q1 2022 | $1,537,000 | -27.9% | 126,507 | -27.7% | 0.25% | -23.2% |
| Q4 2021 | $2,131,000 | -11.9% | 174,948 | +11.7% | 0.33% | -11.4% |
| Q3 2021 | $2,420,000 | +129.4% | 156,625 | +111.9% | 0.37% | +129.2% |
| Q2 2021 | $1,055,000 | -12.3% | 73,902 | +33.4% | 0.16% | -24.1% |
| Q1 2021 | $1,203,000 | +362.7% | 55,397 | +222.4% | 0.21% | +253.3% |
| Q4 2020 | $260,000 | – | 17,184 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |